Mercer Global Advisors’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,821
| Closed | -$268K | – | 2158 |
|
|
2024
Q4 | $268K | Sell |
10,821
-4,568
| -30% | -$113K | ﹤0.01% | 1813 |
|
|
2024
Q3 | $360K | Sell |
15,389
-622
| -4% | -$14.6K | ﹤0.01% | 1528 |
|
|
2024
Q2 | $375K | Sell |
16,011
-1,264
| -7% | -$29.6K | ﹤0.01% | 1465 |
|
|
2024
Q1 | $571K | Buy |
17,275
+5,036
| +41% | +$166K | ﹤0.01% | 1206 |
|
|
2023
Q4 | $333K | Buy |
12,239
+779
| +7% | +$21.2K | ﹤0.01% | 1539 |
|
|
2023
Q3 | $276K | Buy |
11,460
+1,866
| +19% | +$44.9K | ﹤0.01% | 1580 |
|
|
2023
Q2 | $306K | Buy |
9,594
+1,764
| +23% | +$56.3K | ﹤0.01% | 1502 |
|
|
2023
Q1 | $240K | Buy |
+7,830
| New | +$240K | ﹤0.01% | 1632 |
|
|
2022
Q4 | – | Sell |
-4,683
| Closed | -$223K | – | 1932 |
|
|
2022
Q3 | $223K | Buy |
+4,683
| New | +$223K | ﹤0.01% | 1574 |
|